You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2025 › September › 22
Pfizer
10 months ago
Pfizer is spending more than $7 billion to buy biotech Metsera to try to catch cup in the obesity drug market.
Pfizer expands obesity drug pipeline with $7.3 billion deal to buy Metsera ○
Pfizer said on Monday it would acquire weight-loss drug developer Metsera in a deal valued up to $7.3 billion.
Pfizer seals up to $7.3bn takeover of weight loss drugmaker Metsera ○
Deal is the biggest by a large pharma company buying a foothold in the lucrative and fast-growing market
page 1 of 1